Select a relevant service

Evaluate data collected during drug development to maximize the value of a therapeutic product.

Find general strategies and methods used to market a pharmaceutical product or device.

Analyze clinical trial data.

Compare alternative treatments that lead to similar health outcomes.

Develop value story tailored to a payer audience that will determine the appropriate price for treatment.

Assess effects, costs and economic outcomes of treatment. These include cost-effectiveness models and budget impact models.

Economic evaluation in which costs and benefits (outcomes) are expressed in monetary units, to determine if the benefits of an intervention outweigh the costs.

Summary document that presents clinical, economic, and humanistic value of an intervention and associated disease state with the supporting evidence, formulated from the perspective of a particular stakeholder (manufacturer, payer, provider, HTA agency, etc.). See also HTA Submission.

The generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition or to improve the delivery of care.

Measures patient's symptoms, mental, or physical effects of a disease or condition on how the patient functions, recorded by practitioner, provider, or instrument (not by patient).